Literature DB >> 265750

Ultrastructure of osteoblastoma.

G C Steiner.   

Abstract

The ultrastructure of three cases of osteoblastoma is described. The osteoblasts resemble normal osteoblasts with a few exceptions: irregular, indented nuclei, and occasional mitochondria with curved cristae and electron-lucent areas. The osteocytes and osteoclasts basically resemble their normal counterparts. There are also osteoprogenitor cells in different stages of maturation, some containing glycogen. The ultrastructure of an additional case histologically classified as aggressive osteoblastoma is described. It is essentially similar to the previous three cases of typical osteoblastoma. The only exception is the presence of osteoblasts with electron-lucent nuclei and less prominent organelles than the typical osteoblastoma cells have markedly indented and multilobed nuclei, dilated rough endoplasmic reticulum and lipid droplets. However, these differences from osteoblastoma cells are not pathognomonic. The final diagnosis of osteoblastic tumors rests at the light microscopy level.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 265750     DOI: 10.1002/1097-0142(197705)39:5<2127::aid-cncr2820390529>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Psammous desmo-osteoblastoma. Ultrastructural and immunohistochemical evidence for an osteogenic histogenesis.

Authors:  S Störkel; W Wagner; M S Makek
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  Ultrastructural cytology of human osteosarcoma cells.

Authors:  D Katenkamp; D Stiller; G Waldmann
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-12-12

3.  Spinal osteoblastoma in children and adolescents.

Authors:  A L Amacher; A Eltomey
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

4.  Osteoid osteoma and osteoblastoma with clonal chromosome changes.

Authors:  P Dal Cin; R Sciot; I Samson; I De Wever; H Van den Berghe
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.